The percentage of CD3+IgDR+ T cells, CD3+CD4+IgDR+ T and CD19+IgDR+ B cells showed a significant increase (P < 0.05) in PBMCs from both RA patients and healthy controls, which was caused by IgD. This evidence concerns the gene CD19 and rheumatoid arthritis.